Fisher Andrew (CIK 2014301) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-08). Recent activity: Sell VRNA (417,903 shares), Buy VRNA (931,984 shares), Sell VRNA (931,984 shares), Buy VRNA (20,888 shares), Sell VRNA (9,584 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-08 | Verona Pharma plc (VRNA) | General Counsel | Sell | 417,903 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | General Counsel | Buy | 931,984 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | General Counsel | Sell | 931,984 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | General Counsel | Buy | 20,888 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | General Counsel | Sell | 9,584 | $125,934 |
| 2025-07-09 | Verona Pharma plc (VRNA) | General Counsel | Buy | 86,064 | $0 |
| 2025-07-09 | Verona Pharma plc (VRNA) | General Counsel | Sell | 39,464 | $451,468 |
| 2025-06-18 | Verona Pharma plc (VRNA) | General Counsel | Buy | 80,000 | $160,800 |
| 2025-06-18 | Verona Pharma plc (VRNA) | General Counsel | Sell | 80,000 | $922,400 |
| 2025-06-18 | Verona Pharma plc (VRNA) | General Counsel | Buy | 80,000 | $160,800 |
| 2025-05-16 | Verona Pharma plc (VRNA) | General Counsel | Buy | 80,000 | $168,800 |
| 2025-05-16 | Verona Pharma plc (VRNA) | General Counsel | Sell | 80,000 | $685,600 |
| 2025-05-01 | Verona Pharma plc (VRNA) | General Counsel | Buy | 1 | $0 |
| 2025-05-01 | Verona Pharma plc (VRNA) | General Counsel | Buy | 86,064 | $0 |
| 2025-05-01 | Verona Pharma plc (VRNA) | General Counsel | Sell | 26,072 | $234,127 |
Source: SEC Form 4 filings · as of 2025-10-08